Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …

Background Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis
(NASH) account for an increasing proportion of liver disease in the Asia‐Pacific region …

Background: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH) account for a growing proportion of liver disease cases, and there is a need to better …

Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH)
are highly prevalent in the United States, where they are a growing cause of cirrhosis and …

Abstract Background and Aim Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic
steatohepatitis (NASH) account for a large and growing proportion of liver disease burden …

Background: The latest meta-analyses suggest NAFLD is increasing globally. Its limitations
may preclude accurate estimates. We evaluated the global NAFLD burden and its' trends in …

Aim Non‐alcoholic steatohepatitis (NASH) is the progressive form of non‐alcoholic fatty liver
disease (NAFLD) and prevalence is rising in Asia due to increasing rates of urbanization …

With dramatic changes in lifestyles over the last 20 years, nonalcoholic fatty liver disease
(NAFLD) has become the most prevalent liver disorder in China but has not received …

Materials and Methods: Models were used to estimate NAFLD and NASH disease
progression, primarily based on changes in adult prevalence rates of adult obesity and DM …

Background: The increasing burden of non-alcoholic fatty liver disease (NAFLD) worldwide
imposes an emerging public health issue. We perform the current study to estimate the …